Context Capital Management’s Ocean Biomedical, Inc. Common Stock OCEA Stock Holding History

Context Capital Management’s Portfolio OCEA Stock Details OCEA Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q1	–	Sell	-464,841	Closed	-$4.83M	–	361
2022 Q4	$4.83M	Sell	464,841 -33,024	-7%	-$339K	0.35%	87
2022 Q3	$5.07M	Hold	497,865	–	–	0.34%	82
2022 Q2	$5.03M	Hold	497,865	–	–	0.36%	80
2022 Q1	$5.02M	Buy	+497,865	New	+$4.99M	0.33%	82

Other funds holding OCEA

PAMP

Polar Asset Management Partners Toronto, Ontario, Canada $5.01B AUM 35.27% 1-Year Est. Return

Meteora Capital Boca Raton, Florida $1.36B AUM 21.19% 1-Year Est. Return

CCFM

Cohen & Co Financial Management New York $18.3M AUM 73.48% 1-Year Est. Return

Quarry LP New York $558M AUM 23.92% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

HRT Financial New York $40.1B AUM 58.22% 1-Year Est. Return

CSS

Cubist Systematic Strategies Stamford, Connecticut $21B AUM 21.48% 1-Year Est. Return

Millennium Management New York $240B AUM 35.51% 1-Year Est. Return

Arena Investors Purchase, New York $12.5M AUM 0.27% 1-Year Est. Return

Virtu Financial New York $2.41B AUM 48.35% 1-Year Est. Return

Context Capital Management's OCEA Position: Q1 2023 in Review

Context Capital Management sold out of Ocean Biomedical, Inc. Common Stock (OCEA) in Q1 2023, closing a stake of 464,841 shares — an estimated $4.83M sold.

Context Capital Management first reported a position in OCEA in Q1 2022 and held it in 4 quarters. The position peaked at $5.07M in Q3 2022. 17 funds tracked by Wall St. Rank hold OCEA as of Q1 2023.

Context Capital Management reported no remaining Ocean Biomedical, Inc. Common Stock position as of Q1 2023 after selling out during the quarter.
Context Capital Management sold 464,841 Ocean Biomedical, Inc. Common Stock shares in Q1 2023, an estimated $4.83M.
Context Capital Management first reported a position in Ocean Biomedical, Inc. Common Stock in Q1 2022 and held it in 4 quarters.
Context Capital Management's Ocean Biomedical, Inc. Common Stock position peaked at $5.07M in Q3 2022.
17 funds tracked by Wall St. Rank held Ocean Biomedical, Inc. Common Stock as of Q1 2023.

Based on Context Capital Management's 13F filing for Q1 2023, filed 8 May 2023.